Jason is the Head of the Hepatitis C and Drug Use Research Group at the Kirby Institute at UNSW Sydney.

Håvard is a specialist in internal medicine and gastroenterology at Oslo University Hospital and and postdoctor at Akershus University Hospital. His research interests include HCV epidemiology, models of care and general hepatology. He is a founding member of the Norwegian Center for HCV elimination and a former INHSU board member.

Carla Treloar is Director of the Centre for Social Research in Health and the Social Policy Research Centre, UNSW Sydney.

Beth Catlett is a Final year PhD student, her thesis focuses on emerging technologies and implementation science to increase uptake and linkage to care in people who inject drugs. Beth is also the dried blood spot coordinator at St Vincent’s AMR where focusing on BBV testing, primarily HIV and HCV.

Internist, Infectious disease specialist and epidemiologist engaged in the HCV-management of opioid agonist therapy patients, founder member of SAMMSU (Swiss Association for the Medical Management in Substance Users), member of the Swiss Hepatitis Strategy, special interest in minimally-invasive diagnostic tests and treatment on-site, Swiss and German citizenship

Dr. Norton is an assistant professor of medicine in the Division of General Internal Medicine at Albert Einstein College of Medicine/ Montefiore Medical Center. She conducts research to improve HCV treatment for people who inject drugs. She is also the medical director of a syringe exchange program in East Harlem.

Dr. Korthuis is Professor of Medicine and Public Health at Oregon Health & Science University where he leads the Addiction Medicine Section. His research focuses on improving harm reduction and treatment for people who use drugs. He serves as principal investigator for multiple NIH trials.

Dr. Rosenau is an Associate Professor of Medicine, Division of Gastroenterology and Hepatology at the University of Kentucky, where he is the Acting Director of hepatology.

Michael is a PhD student and research assistant working on the ACCESS surveillance project.

Alison Marshall is a postdoctoral researcher with a background in clinical epidemiology and social science. Her work is focused on increasing access to hepatitis C treatment for persons with a history of injection drug use.

Dave is a lecturer in adult nursing at Glasgow Caledonian University, and remains a registered nurse. He worked clinically as a HCV nurse specialist for a number of years, before moving into academia in 2017.